Literature DB >> 23287625

Genetic evidence of PTPN22 effects on chronic lymphocytic leukemia.

Scott J Hebbring, Susan L Slager, Narendranath Epperla, Joseph J Mazza, Zhan Ye, Zhiyi Zhou, Sara J Achenbach, Daniel A Vasco, Timothy G Call, Kari G Rabe, Neil E Kay, Neil E Caporaso, Mark C Lanasa, Nicola J Camp, Sara S Strom, Lynn R Goldin, James R Cerhan, Murray H Brilliant, Steven J Schrodi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23287625      PMCID： PMC5091216          DOI： 10.1182/blood-2012-08-450221

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   25.476


× No keyword cloud information.
  10 in total

1.  Autoimmune-associated PTPN22 R620W variation reduces phosphorylation of lymphoid phosphatase on an inhibitory tyrosine residue.

Authors:  Edoardo Fiorillo; Valeria Orrú; Stephanie M Stanford; Yingge Liu; Mogjiborahman Salek; Novella Rapini; Aaron D Schenone; Patrizia Saccucci; Lucia G Delogu; Federica Angelini; Maria Luisa Manca Bitti; Christian Schmedt; Andrew C Chan; Oreste Acuto; Nunzio Bottini
Journal:  J Biol Chem       Date:  2010-06-09       Impact factor: 5.157

2.  Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs B cell signaling.

Authors:  Adrian F Arechiga; Tania Habib; Yantao He; Xian Zhang; Zhong-Yin Zhang; Andrew Funk; Jane H Buckner
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

3.  Overexpression of the autoimmunity-associated phosphatase PTPN22 promotes survival of antigen-stimulated CLL cells by selectively activating AKT.

Authors:  Roberto Negro; Stefania Gobessi; Pablo G Longo; Yantao He; Zhong-Yin Zhang; Luca Laurenti; Dimitar G Efremov
Journal:  Blood       Date:  2012-05-08       Impact factor: 22.113

4.  Marshfield Clinic Personalized Medicine Research Project (PMRP): design, methods and recruitment for a large population-based biobank.

Authors:  Catherine A McCarty; Russell A Wilke; Philip F Giampietro; Steve D Wesbrook; Michael D Caldwell
Journal:  Per Med       Date:  2005-03       Impact factor: 2.512

Review 5.  Lymphoid tyrosine phosphatase and autoimmunity: human genetics rediscovers tyrosine phosphatases.

Authors:  Stephanie M Stanford; Tomas M Mustelin; Nunzio Bottini
Journal:  Semin Immunopathol       Date:  2010-03-04       Impact factor: 9.623

6.  The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans.

Authors:  Laurence Menard; David Saadoun; Isabelle Isnardi; Yen-Shing Ng; Greta Meyers; Christopher Massad; Christina Price; Clara Abraham; Roja Motaghedi; Jane H Buckner; Peter K Gregersen; Eric Meffre
Journal:  J Clin Invest       Date:  2011-08-01       Impact factor: 14.808

7.  Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL.

Authors:  Susan L Slager; Kari G Rabe; Sara J Achenbach; Celine M Vachon; Lynn R Goldin; Sara S Strom; Mark C Lanasa; Logan G Spector; Laura Z Rassenti; Jose F Leis; Nicola J Camp; Martha Glenn; Neil E Kay; Julie M Cunningham; Curtis A Hanson; Gerald E Marti; J Brice Weinberg; Vicki A Morrison; Brian K Link; Timothy G Call; Neil E Caporaso; James R Cerhan
Journal:  Blood       Date:  2010-12-03       Impact factor: 22.113

8.  The autoimmune disease-associated PTPN22 variant promotes calpain-mediated Lyp/Pep degradation associated with lymphocyte and dendritic cell hyperresponsiveness.

Authors:  Jinyi Zhang; Naima Zahir; Qiuhong Jiang; Helen Miliotis; Stephanie Heyraud; Xianwang Meng; Baoxia Dong; Gang Xie; Frank Qiu; Zhenyue Hao; Christopher A McCulloch; Edward C Keystone; Alan C Peterson; Katherine A Siminovitch
Journal:  Nat Genet       Date:  2011-08-14       Impact factor: 38.330

9.  A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes.

Authors:  Nunzio Bottini; Lucia Musumeci; Andres Alonso; Souad Rahmouni; Konstantina Nika; Masoud Rostamkhani; James MacMurray; Gian Franco Meloni; Paola Lucarelli; Maurizio Pellecchia; George S Eisenbarth; David Comings; Tomas Mustelin
Journal:  Nat Genet       Date:  2004-03-07       Impact factor: 38.330

10.  Autoimmunity in primary antibody deficiency is associated with protein tyrosine phosphatase nonreceptor type 22 (PTPN22).

Authors:  Gary Y J Chew; Umang Sinha; Paul A Gatenby; Theo DeMalmanche; Stephen Adelstein; Roger Garsia; Pravin Hissaria; Martyn A French; Anastasia Wilson; Belinda Whittle; Philippa Kirkpatrick; D Sean Riminton; David A Fulcher; Matthew C Cook
Journal:  J Allergy Clin Immunol       Date:  2012-07-31       Impact factor: 10.793
  10 in total
  6 in total

1.  Differential Lipid Response to Statins Is Associated With Variants in the BUD13-APOA5 Gene Region.

Authors:  Sarah E OʼBrien; Steven J Schrodi; Zhan Ye; Murray H Brilliant; Salim S Virani; Ariel Brautbar
Journal:  J Cardiovasc Pharmacol       Date:  2015-08       Impact factor: 3.105

Review 2.  PTPN22: the archetypal non-HLA autoimmunity gene.

Authors:  Stephanie M Stanford; Nunzio Bottini
Journal:  Nat Rev Rheumatol       Date:  2014-07-08       Impact factor: 20.543

Review 3.  Autoimmunity checkpoints as therapeutic targets in B cell malignancies.

Authors:  Markus Müschen
Journal:  Nat Rev Cancer       Date:  2018-01-05       Impact factor: 60.716

Review 4.  Tyrosine phosphatase PTPN22: multifunctional regulator of immune signaling, development, and disease.

Authors:  Nunzio Bottini; Erik J Peterson
Journal:  Annu Rev Immunol       Date:  2013-12-18       Impact factor: 28.527

5.  Genome wide association study of SNP-, gene-, and pathway-based approaches to identify genes influencing susceptibility to Staphylococcus aureus infections.

Authors:  Zhan Ye; Daniel A Vasco; Tonia C Carter; Murray H Brilliant; Steven J Schrodi; Sanjay K Shukla
Journal:  Front Genet       Date:  2014-05-09       Impact factor: 4.599

6.  PTPN22 Silencing in Human Acute T-Cell Leukemia Cell Line (Jurkat Cell) and its Effect on the Expression of miR-181a and miR-181b.

Authors:  Elham Baghbani; Vahid Khaze; Sanam Sadreddini; Ahad Mokhtarzadeh; Behzad Mansoori; Ali Mohammadi; Vida Vatankhahan; Parisa Toosi; Behzad Baradaran
Journal:  Adv Pharm Bull       Date:  2018-06-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.